BiobadaBrasil: Brazilian biologic registry.
نویسنده
چکیده
109 Rev Bras Reumatol 2011;51(2):109-112 In this volume, the article Brazilian Biologic Registry: BiobadaBrasil implementation process and preliminary, the authors described the implementation of the registry “Monitoring the Brazilian Registry of Biological Therapies in Rheumatic Diseases – BiobadaBrasil” promoted by the Brazilian Society of Rheumatology (BSR), and presented data from the first ten months of the study providing this registry available to all rheumatologists and the Brazilian Society. The registry implementation was a proposal from the “First Forum of New Resources Rheumatology”, held in Sao Paulo in July 2007, to create a national database of biological agents. Afterwards, a contract was signed with the BSR, PANLAR and Spanish Society of Rheumatology (SSR) in order to participate in BIOBADAMERICA in November of that year. This action was the result of the vision of President of SBR (2006-08), Fernando Neubarth, that participate in a registry already consolidated as BIOBADASER and rely on its support and advice would facilitate the implementation and consolidation of the Brazilian registry. Using a simple online platform makes this registry accessible to all study centers with internet access and all rheumatologists interested in participating. The implementation process is described in the article, with a training phase, the BiobadaBrasil I, with the system and documents adaptation from Spanish to Portuguese, staff training, and gradual implementation. In April 2009, it was officially presented in the “XX Brazilian Conference Rheumatology” in Natal, and rheumatologists were invited to participate. Throughout this period, the study was presented and discussed in all SBR events and its disclosure was made at the company website and magazine. The President of BSR (2008-10), Ieda Laurindo, actively supported the study, encouraged and guided the implementation team, and was the main responsible for implementing the study in 23 centers and including 1,037 patients until February 2010. BiobadaBrasil: Brazilian Biologic Registry
منابع مشابه
Brazilian biologic registry: BiobadaBrasil implementation process and preliminary results.
OBJECTIVES The present study aimed at describing the implementation process of a national registry in a developing country (Brazil) and at reporting the main preliminary results of the BiobadaBrasil registry. MATERIAL AND METHODS Through a PANLAR agreement, the Biobadaser protocol was used as a model for implementing the new registry in our country. During the first two years of this effort, ...
متن کاملBrazilian Registry of Cardiovascular Surgery in Adults Fully Operational
Brazilian Journal of Cardiovascular Surgery The Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV ) has taken great pleasure and pride in announcing that the Brazilian Registry of Cardiovascular Surgery in Adults (The Bypass Registry) is currently fully operational and the inclusion has exceeded 1500 patients in the first nine months of operation. This success is the aftermath of the serio...
متن کاملRationality and methods of ACCEPT registry - Brazilian registry of clinical practice in acute coronary syndromes of the Brazilian Society of Cardiology.
BACKGROUND Assessing the Brazilian clinical practice in patients with acute coronary syndrome, in public and private hospitals to identify gaps in the incorporation of clinical interventions with proven benefit. OBJECTIVE To develop a registry of patients diagnosed with acute coronary syndrome to assess demographics, morbidity, mortality, and standard practice in the care of this condition. B...
متن کاملDrug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
BACKGROUND Drug survival is a marker for treatment sustainability in chronic diseases such as psoriasis. OBJECTIVE The aim of these analyses was to assess survival of biologic treatments in the PSOriasis Longitudinal Assessment and Registry (PSOLAR). METHODS PSOLAR is a large, prospective, international, disease-based registry of patients with psoriasis receiving (or eligible for) systemic ...
متن کاملUse of data from multiple registries in studying biologic discontinuation: challenges and opportunities.
Many studies have been conducted concerning discontinuation of biologic disease-modifying anti-rheumatic drugs (DMARD), but mainly in trial settings which result in limited generalisability. Registry studies can complement the current literature of biologic DMARD discontinuation by providing more generalisable information. However, it may be necessary to combine registries to increase power and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Revista brasileira de reumatologia
دوره 51 2 شماره
صفحات -
تاریخ انتشار 2011